Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
Elinor J. Sawyer(King's College London), Javier Benı́tez(Spanish National Cancer Research Centre), Paolo De Ieso(Royal Marsden NHS Foundation Trust), Miriam Dwek(University of Cambridge), Peter A. Fasching(Universitätsklinikum Erlangen), Jelle Wesseling(Leiden University Medical Center), Richard S. Houlston(Institute of Cancer Research), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Michele Caneppele(Queen Mary University of London), Thérèse Truong(Université Paris-Sud), F Marmé(Heidelberg University), Salpie Nowinski(Guy's Hospital), Pascal Guénel(Inserm), Roger L. Milne(The University of Melbourne), Sten Cornelissen, Arif B. Ekici(University Medical Center Groningen), Christos Petridis(National Health Service), Rebecca Roylance(University College London Hospitals NHS Foundation Trust), Mark N. Brook(Institute of Cancer Research), Cheryl Gillett(King's College London), José Ignacio Arias Pérez, Olivia Fletcher(Breast Cancer Care), Elena Provenzano(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Ruth Swann(Karolinska University Hospital), Renske Keeman(The Netherlands Cancer Institute), Børge G. Nordestgaard(Gentofte Hospital), Pierre Kerbrat(Aarhus University Hospital), Christof Sohn, Efterpi Papouli(King's College London), Sebastian M. Jud, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Pierre Laurent‐Puig(Inserm), Patricia Gorman(The Honourable Society of Lincoln's Inn), Gillian Ross(Royal Marsden NHS Foundation Trust), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Primitiva Menéndez(City of Hope), Sune F. Nielsen(Herlev Hospital), Carmel Apicella(The University of Melbourne), Katherine-Anne Perkins(University of Westminster), Julian Peto(University of Helsinki), Henrik Flyger(Herlev Hospital), Andrew M. Hanby(University of Leeds), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Sarah E. Pinder(St Thomas' Hospital), Nichola Johnson(Institute of Cancer Research)
Cited by 49
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k